Prudential plc Announcement -- Schedule 10 -- Notification of Major Interests in Shares
LONDON, March 22, 2004 (PRIMEZONE) --
Grace Reksten Skaugen nominated to the Board of Atlas Copco AB
STOCKHOLM, Sweden, March 22, 2004 (PRIMEZONE) -- At the Annual General Meeting of Atlas Copco AB, to be held April 27, 2004, shareholders will vote on Grace Reksten Skaugen, Norwegian, as a new member of the Board of Directors.
CAMBRIDGE, U.K., March 22, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, together with The Wellcome Trust, the Institute of Cancer Research and Cancer Research Technology today announced an exclusive collaboration relating to the discovery of novel drugs against the cancer target BRAF. BRAF was first identified as a key target implicated in a variety of cancers in 2002 when scientists from The Institute of Cancer Research, in partnership with scientists from the Cancer Genome Project at The Wellcome Trust Sanger Institute in Cambridge, discovered that the gene is involved in up to 70% of certain cancer types including malignant melanoma.
VENTURE PRODUCTION -- Video Interviews with CEO and FD
ABERDEENSHIRE, U.K., March 22, 2004 (PRIMEZONE) -- Preliminary results
WOLSELEY -- Video Interviews With CEO and FD
WORCESTERSHIRE, U.K., March 22, 2004 (PRIMEZONE) -- Wolseley PLC: Interim results
Sampo Commences Financing Arrangements For IF Transaction
STOCKHOLM, Sweden, March 22, 2004 (PRIMEZONE) -- The Board of Directors of Sampo plc has today decided to launch on the international capital markets a EUR 600 million callable subordinated notes, eligible for inclusion in the capital adequacy calculation. Sampo seeks listing of the above notes for public trading in the London Stock Exchange.
CeBIT at HANNOVER, Germany, March 22 2004 (PRIMEZONE) -- Trintech Group Plc (Nasdaq:TTPA) (Prime Standard:TTP), a leading provider of transaction management and payment infrastructure solutions, today announced the launch of OpenPay 2000 a GPRS-enabled mobile top-up solution that can be used in indoor and outdoor vending environments.
LONDON, March 22, 2004 (PRIMEZONE) -- Antisoma plc (LSE:ASM), the biopharmaceutical company specialising in the development of novel anti-cancer drugs, will today hold an R&D update for analysts and investors. This will focus on a number of the Company's earlier stage clinical and preclinical products.
BG Group to Make Agreed Offer For Further Exploration and Production Interests in Trinidad & Tobago
READING, England, March 22, 2004 (PRIMEZONE) -- BG Group announced today that it intends to make a recommended take-over offer of Canadian $5.10 per share for all of the shares in Aventura Energy Inc. (Aventura), through its wholly-owned Canadian subsidiary, BG Canada Ltd. The total purchase price to be paid by BG Group is approximately Canadian $228 million (US$171 million)
DigiLava Extends Dial-Up Contract and Partner with PurespeedPlus
SAN FRANCISCO, March 19, 2004 (PRIMEZONE) -- DigiLava, Inc. (Pink Sheets:DGLV) today announced it has signed a new contract with PurespeedPlus, one of the nation's leading virtual dial access providers, that will continue to make PurespeedPlus the exclusive provider of wholesale dial-up services to the San Francisco-based ASP and BSP through mid-2005.
